XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   71,047      
Beginning balance at Dec. 31, 2022 $ 309,965 $ 71 $ 635,668 $ (2,688) $ (323,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon partial conversion of the 2023 convertible senior notes (in shares)   2      
Issuance of common stock upon partial conversion of the 2023 convertible senior notes 0   0    
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes (in shares)   (371)      
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes 74,453   74,453    
Issuance of common stock upon exercise of stock options (in shares)   436      
Issuance of common stock upon exercise of stock options 8,315   8,315    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,378      
Issuance of common stock upon vesting of restricted stock units 1 $ 2 (1)    
Issuance of common stock under ESPP (in shares)   204      
Issuance of common stock under ESPP 9,444   9,444    
Stock-based compensation 159,208   159,208    
Other comprehensive income 1,890     1,890  
Net loss (69,406)       (69,406)
Ending balance (in shares) at Sep. 30, 2023   72,696      
Ending balance at Sep. 30, 2023 493,870 $ 73 887,087 (798) (392,492)
Beginning balance (in shares) at Jun. 30, 2023   72,180      
Beginning balance at Jun. 30, 2023 458,799 $ 72 832,197 (1,397) (372,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   57      
Issuance of common stock upon exercise of stock options 1,334   1,334    
Issuance of common stock upon vesting of restricted stock units (in shares)   459      
Issuance of common stock upon vesting of restricted stock units 0 $ 1 (1)    
Stock-based compensation 53,557   53,557    
Other comprehensive income 599     599  
Net loss (20,419)       (20,419)
Ending balance (in shares) at Sep. 30, 2023   72,696      
Ending balance at Sep. 30, 2023 493,870 $ 73 887,087 (798) (392,492)
Beginning balance (in shares) at Dec. 31, 2023   73,317      
Beginning balance at Dec. 31, 2023 538,085 $ 73 942,280 582 (404,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of new capped calls associated with the 2029 convertible senior notes (93,438)   (93,438)    
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes 539   539    
Issuance of common stock upon exercise of stock options (in shares)   21      
Issuance of common stock upon exercise of stock options 423   423    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,661      
Issuance of common stock upon vesting of restricted stock units 2 $ 2      
Issuance of common stock under ESPP (in shares)   209      
Issuance of common stock under ESPP 9,522   9,522    
Stock-based compensation 133,579   133,579    
Other comprehensive income 1,246     1,246  
Net loss (24,372)       (24,372)
Ending balance (in shares) at Sep. 30, 2024   75,208      
Ending balance at Sep. 30, 2024 565,586 $ 75 992,905 1,828 (429,222)
Beginning balance (in shares) at Jun. 30, 2024   74,719      
Beginning balance at Jun. 30, 2024 525,878 $ 75 951,048 (502) (424,743)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   6      
Issuance of common stock upon exercise of stock options 26   26    
Issuance of common stock upon vesting of restricted stock units (in shares)   483      
Issuance of common stock upon vesting of restricted stock units 0 $ 0      
Stock-based compensation 41,831   41,831    
Other comprehensive income 2,330     2,330  
Net loss (4,479)       (4,479)
Ending balance (in shares) at Sep. 30, 2024   75,208      
Ending balance at Sep. 30, 2024 $ 565,586 $ 75 $ 992,905 $ 1,828 $ (429,222)